The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
The cannabinoid system and immune modulation
Open accessAbstract
Studies on the effects of marijuana smoking have evolved into the discovery and description of the endocannabinoid system. To date, this system is composed of two receptors, CB1 and CB2, and endogenous ligands including anandamide, 2-arachidonoyl glycerol, and others. CB1 receptors and ligands are found in the brain as well as immune and other peripheral tissues. Conversely, CB2 receptors and ligands are found primarily in the periphery, especially in immune cells. Cannabinoid receptors are G protein-coupled receptors, and they have been linked to signaling pathways and gene activities in common with this receptor family. In addition, cannabinoids have been shown to modulate a variety of immune cell functions in humans and animals and more recently, have been shown to modulate T helper cell development, chemotaxis, and tumor development. Many of these drug effects occur through cannabinoid receptor signaling mechanisms and the modulation of cytokines and other gene products. It appears the immunocannabinoid system is involved in regulating the brain-immune axis and might be exploited in future therapies for chronic diseases and immune deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,277
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Lefkowitz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18677 · Cited by 1,044
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 875
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Ohno-Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 845
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor
Hanuš, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 762
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Galve-Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 682
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 665
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
Cannabis: pharmacology and toxicology in animals and humans
ADAMS, I. B., & MARTIN, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 570
Hollister, L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 497
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez, C., CEBALLOS, M. L. D., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve‐Roperh, I., Huffman, J. W., y Cajal, S. R., & Guzmán, M. (2001) · Cancer Research · Cited by 422
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
De Petrocellis, L., Melck, D., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., & Di Marzo, V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8375 · Cited by 413
Marijuana and medicine: assessing the science base
(1999) · Choice Reviews Online · doi:10.5860/choice.37-2206 · Cited by 410
Hillard, C. J., Manna, S., Greenberg, M. J., DiCamelli, R., Ross, R. A., Stevenson, L. A., Murphy, V., Pertwee, R. G., & Campbell, W. B. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38289-8 · Cited by 374
Cannabinoid‐receptor expression in human leukocytes
BOUABOULA, M., RINALDI, M., CARAYON, P., CARILLON, C., DELPECH, B., SHIRE, D., LE FUR, G., & CASELLAS, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 367
Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids
Miyaura, H., & Iwata, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1087 · Cited by 361
Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 358
Kohm, A. P., & Sanders, V. M. (2001) · PubMed · Cited by 357
Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0356 · Cited by 348
Carlisle, S. J., Marciano-Cabral, F., Staab, A., Ludwick, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 344
Felder, C. C., Nielsen, A., Briley, E. M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D. N., Richardson, J. M., Riggin, R. M., Koppel, G. A., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00891-5 · Cited by 326
Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
Zhang, Z., Morgenstern, H., Spitz, M. R., Tashkin, D. P., Yu, G. P., Marshall, J. R., Hsu, T., & Schantz, S. P. (1999) · PubMed · Cited by 302
Inhibition of tumor angiogenesis by cannabinoids
Blázquez, C., Casanova, M. L., Planas, A., Gómez del Pulgar, T., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
McKallip, R. J., Lombard, C., Fisher, M., Martin, B. R., Ryu, S., Grant, S., Nagarkatti, P. S., & Nagarkatti, M. (2002) · Blood · doi:10.1182/blood-2002-01-0098 · Cited by 288
Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi‐Carmona, M., Calandra, B., Le Fur, G., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 286
Cannabinoid receptors and the regulation of immune response
Berdyshev, E. V. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00195-x · Cited by 280
Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., & Di Marzo, V. (2000) · Endocrinology · doi:10.1210/endo.141.1.7239 · Cited by 265
Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations
Eisenstein, T. K., & Hilburger, M. E. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00219-1 · Cited by 262
Szabo, I., Chen, X.-H., Xin, L., Adler, M. W., Howard, O. M. Z., Oppenheim, J. J., & Rogers, T. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102327699 · Cited by 255
Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253
Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 252
Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 248
Trends in histamine research: new functions during immune responses and hematopoiesis
Schneider, E., Rolli-Derkinderen, M., Arock, M., & Dy, M. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02215-9 · Cited by 236
Cannabinoid receptors and immunity
Klein, T. W., Newton, C., & Friedman, H. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 234
Self-citationΔ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells
Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., & Roth, M. D. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00370-3 · Cited by 234
Felder, C. C., Joyce, K. E., Briley, E. M., Glass, M., Mackie, K. P., Fahey, K. J., Cullinan, G. J., Hunden, D. C., Johnson, D. W., Chaney, M. O., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37189-7 · Cited by 233
Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production
BALDWIN, G. C., TASHKIN, D. P., BUCKLEY, D. M., PARK, A. N., DUBINETT, S. M., & ROTH, M. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9704146 · Cited by 230
Warner, J. F., & Dennert, G. (1982) · Nature · doi:10.1038/300031a0 · Cited by 224
The Cannabinoid System and Cytokine Network
Klein, T. W., Lane, B., Newton, C. A., & Friedman, H. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 214
Self-citationEnantiomeric cannabinoids: stereospecificity of psychotropic activity
Mechoulam, R., Feigenbaum, J. J., Lander, N., Segal, M., Järbe, T. U. C., Hiltunen, A. J., & Consroe, P. (1988) · Experientia · doi:10.1007/bf01959156 · Cited by 208
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessègue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 208
Marijuana, immunity and infection
Klein, T. W., Friedman, H., & Specter, S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00226-9 · Cited by 192
Self-citationJeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190
Cloning and molecular characterization of the rat CB2 cannabinoid receptor
Brown, S. M., Wager-Miller, J., & Mackie, K. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00341-x · Cited by 190
Jacobsson, S. O. P., Wallin, T., & Fowler, C. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29216-8 · Cited by 186
Norepinephrine: a messenger from the brain to the immune system
Kohm, A. P., & Sanders, V. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01747-3 · Cited by 184
Cannabinoids and multiple sclerosis
Pertwee, R. G. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00255-3 · Cited by 181
Schwarz, H., Blanco, F. J., & Lotz, M. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90152-x · Cited by 180
Presence and regulation of the endocannabinoid system in human dendritic cells
Matias, I., Pochard, P., Orlando, P., Salzet, M., Pestel, J., & Di Marzo, V. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03078.x · Cited by 179
Carayon, P., Marchand, J., Dussossoy, D., Derocq, J.-M., Jbilo, O., Bord, A., Bouaboula, M., Galiègue, S., Mondière, P., Pénarier, G., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3605 · Cited by 178
Huffman, J. W., Yu, S., Showalter, V., Abood, M. E., Wiley, J. L., Compton, D. R., Martin, B. R., Bramblett, R. D., & Reggio, P. H. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960394y · Cited by 173
Melck, D., Rueda, D., Galve-Roperh, I., De Petrocellis, L., Guzmán, M., & Di Marzo, V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01639-7 · Cited by 168
Alberich Jordà, M., Verbakel, S. E., Valk, P. J. M., Vankan-Berkhoudt, Y. V., Maccarrone, M., Finazzi-Agrò, A., Löwenberg, B., & Delwel, R. (2002) · Blood · doi:10.1182/blood.v99.8.2786 · Cited by 160
Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes
Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041525.x · Cited by 159 · cited 1×
“it [50], suggesting these receptors activate factors other than”
BackgroundKlein, T. W., Newton, C. A., Nakachi, N., & Friedman, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6461 · Cited by 159
Self-citationProtein Kinase C Disrupts Cannabinoid Actions by Phosphorylation of the CB1 Cannabinoid Receptor
García, D. E., Brown, S. M., Hille, B., & Mackie, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02834.1998 · Cited by 155
Antinociceptive (aminoalkyl)indoles
Bell, M. R., D'Ambra, T. E., Kumar, V., Eissenstat, M. A., Herrmann, J. L., Wetzel, J. R., Rosi, D., Philion, R. E., & Daum, S. J. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00107a034 · Cited by 154
Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease
Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151
Sidney, S., Beck, J. E., Tekawa, I. S., Quesenberry, C. P., & FRIEDMAN, G. D. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.4.585 · Cited by 147
Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein
Chakrabarti, A., Onaivi, E. S., & Chaudhuri, G. (1995) · DNA sequence · doi:10.3109/10425179509020870 · Cited by 140
Newton, C., Klein, T., & Friedman, H. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4015-4020.1994 · Cited by 137
Self-citationCondie, R. B., Herring, A. C., Koh, W. S., Lee, M., & Kaminski, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13175 · Cited by 133
Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 132
Leroy, S., Griffon, N., Bourdel, M., Olié, J., Poirier, M. F., & Krebs, M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10038 · Cited by 115
Morphine directs T cells toward Th2 differentiation
Roy, S., Balasubramanian, S., Sumandeep, S., Charboneau, R., Wang, J., Melnyk, D. L., Beilman, G. J., Vatassery, R., & Barke, R. A. (2001) · Surgery · doi:10.1067/msy.2001.116033 · Cited by 113
Zhu, W., Friedman, H. P., & Klein, T. (1998) · PubMed · Cited by 113
Self-citationZhuang, S.-Y., Kittler, J. T., Grigorenko, E. V., Kirby, M. T., Sim, L. J., Hampson, R. E., Childers, S. R., & Deadwyler, S. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00232-0 · Cited by 110
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Calandra, B., Portier, M., Kernéis, A., Delpech, M., Carillon, C., Fur, G. L., Ferrara, P., & Shire, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00349-0 · Cited by 108
Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01122-0 · Cited by 100
Self-citationDerocq, J., Jbilo, O., Bouaboula, M., Ségui, M., Clère, C., & Casellas, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15621 · Cited by 100
A cannabinoid derived prototypical analgesic
Melvin, L. S., Johnson, M. R., Harbert, C. A., Milne, G. M., & Weissman, A. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00367a013 · Cited by 97
Effects of delta-9-tetrahydrocannabinol on human immune function and host defense
Roth, M. D., Baldwin, G. C., & Tashkin, D. P. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00159-7 · Cited by 91
Cannabinoids and the Immune System
Klein, T., Newton, C. A., & Friedman, H. P. (2001) · Pain Research and Management · doi:10.1155/2001/326867 · Cited by 91
Self-citationPrévot, V., Rialas, C. M., Croix, D., Salzet, M., Dupouy, J., Poulain, P., Beauvillain, J., & Stefano, G. B. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00066-3 · Cited by 89
Regulation of interleukin-12 production byG-protein-coupled receptors
Braun, M., & Kelsall, B. L. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01357-5 · Cited by 74
Shay, A. H., Choi, R., Whittaker, K., Salehi, K. K., Kitchen, C. M. R., Tashkin, D. P., Roth, M. D., & Baldwin, G. C. (2003) · The Journal of Infectious Diseases · doi:10.1086/368370 · Cited by 71
Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation.
Daaka, Y., Friedman, H. P., & Klein, T. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12361-6 · Cited by 67
Self-citationCohen, M. W., Klein, E., Kuten, A., Fried, G., Zinder, O., & Pollack, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10488 · Cited by 62
Nong, L., Newton, C. A., Cheng, Q., Friedman, H. P., Roth, M. D., & Klein, T. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00113-3 · Cited by 61
Self-citationAutocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β
Gardner, B. K., Zu, L. X., Sharma, S. P., Liu, Q., Makriyannis, A., Tashkin, D. P., & Dubinett, S. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6179 · Cited by 59
Tindall, B., Cooper, D. A., Donovan, B. J., et al. (1988) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1988.tb02232.x · Cited by 59
9-Tetrahydrocannabinol, Cytokines, and Immunity to Legionella pneumophila
Klein, T., Newton, C., Zhu, W., Daaka, Y., & Friedman, H. P. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-209-43897b · Cited by 56
Self-citationSinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00181-1 · Cited by 55
Faubert, B. L., & Kaminski, N. E. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.2.259 · Cited by 50
Christie, M. J., & Vaughan, C. W. (2001) · Nature · doi:10.1038/35069167 · Cited by 48
Schatz, A. R., Kessler, F. K., & Kaminski, N. E. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90414-k · Cited by 46
Massi, P., Sacerdote, P., Ponti, W., Fuzio, D., Manfredi, B., Viganò, D., Rubino, T., Bardotti, M., & Parolaro, D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00177-5 · Cited by 42
Biosynthesis and turnover of anandamide and other N‐acylethanolamines in peritoneal macrophages
Kuwae, T., Shiota, Y., Schmid, P. C., Krebsbach, R. J., & Schmid, H. H. O. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01226-0 · Cited by 41
Marijuana and medicine assessing the science base
Joy, J. E., Watson, S. J., Benson, J. A., & Institute of Medicine (U.S.) (1999) · Cited by 39
Noe, S. N., Newton, C. A., Widen, R. E., Friedman, H., & Klein, T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00349-0 · Cited by 38
Self-citationDaaka, Y., Zhu, W., Friedman, H., & Klein, T. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.301 · Cited by 38
Self-citationSmith, S. R., Terminelli, C., & Denhardt, G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01142-6 · Cited by 32
How Cannabinoids Work in the Brain
Barinaga, M. (2001) · Science · doi:10.1126/science.291.5513.2530 · Cited by 27
Yebra, M., Klein, T., & Friedman, H. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90009-e · Cited by 27
Self-citationThe effect of chronic marihuana usage on the immunological status of rhesus monkeys
Daul, C. B., & Heath, R. G. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90438-5 · Cited by 23
Expression of Cannabinoid Receptor mRNA in Murine and Human Leukocytes
Daaka, Y., Klein, T., & Friedman, H. P. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1951-5_13 · Cited by 22
Self-citation
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Gillison, M. L., D'Souza, G., Westra, W., Sugar, E., Xiao, W., Begum, S., & Viscidi, R. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn025 · Cited by 1,543
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Metadata
- Authors
- Klein, T. W., Newton, C., Larsen, K., Lu, L., Perkins, I., Nong, L., & Friedman, H.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-01
- Volume
- 74
- Issue
- 4
- Pages
- 486-496
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2146904199
- Cited by
- 524
- References
- 118
- FWCI
- 15.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.